10.07.2015 Views

full pdf of issue - Middle East Journal of Family Medicine

full pdf of issue - Middle East Journal of Family Medicine

full pdf of issue - Middle East Journal of Family Medicine

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CLINICAL RESEARCH AND METHODSPathophysiology <strong>of</strong> MigraineABSTRACTMigraine is a neurovascular disordercharacterized by a unilateral mild orsevere headache lasting from a fewhours to as long as three days. It hasbeen recently shown in many studiesthat this disorder has a firm andcomplicated genetic background thatexposes individuals to a higher susceptibilityto migraine attacks. Oldtheories used to focus on the vascularchanges and the subsequentblood flow alterations in the brain toexplain the different symptoms occurringduring migraines. New theorieson the other hand are sheddingmore light on the involvement <strong>of</strong> thenervous system in the brain, primarilythe trigeminal nerve in the brainstem, considering it the primarycause for the initiation <strong>of</strong> migraineattacks. Changes in blood vessels inthe brain are believed to be an epiphenomenononly.In this article, the pathophysiology <strong>of</strong>a migraine attack is explained on thebasis <strong>of</strong> the unified theory that triesto integrate all the available scientificdata about migraine.M. Bashir Abiad, BS BiologyPathophysiology <strong>of</strong>migraine:Migraine is best defined as achronic disorder <strong>of</strong> the centralnervous system. It is characterizedby a series <strong>of</strong> events beginningwith the abnormal over-excitement<strong>of</strong> certain nerve cells in the brain.These neurons release a pool <strong>of</strong>chemicals that stimulate the brain’sblood vessels to swell (vasodilation),and create an inflammatory reactionin the affected area. As a result,the person suffers from a severeand pulsating unilateral headache,accompanied by nausea, vomiting,visual and auditory problems, tingling<strong>of</strong> the face and extremities, as well asfatigue, drowsiness and yawning [1] .Migraine attacks may be triggeredby many different factors, includinghormonal changes (observedin menstrual cycles, with oralcontraception or estrogen replacementtherapy, which explains why nearly74% <strong>of</strong> migraine sufferers in theUnited States are females [2] ). Othertriggers involve dietary factors (likechocolate; alcohol; cheese; yoghurt;fermented, decayed or marinatedmeat and anything that may containtyramine, a monoamine which isproduced by the decarboxylation <strong>of</strong>tyrosine during fermentation or decayand that causes the release <strong>of</strong> storedmonoamines (dopamine, epinephrineor norepinephrine) [3] . Changes in sleeppatterns, emotional disturbances(like excitement, fear, anxiety, anger,and stress), allergic reactions, andenvironmental factors (like weatherchanges, bright light, loud noise,certain odors and perfumes) mayalso trigger migraine attacks [4] . Eachperson, with his/her unique geneticbackground, is at a certain threshold<strong>of</strong> neuronal excitability in his/herbrain. In fact, specific allele mutationshave been recently discovered to beinvolved in exposing the individualto higher risks to migraine attacks:four different missense mutations inthe α 1Asubunit <strong>of</strong> the P/Q – type <strong>of</strong>voltage-gated Ca 2+ on chromosome19 affect the release <strong>of</strong> serotonin,a vasoconstrictor, in midbrain [5][6][7] .ATP1A2 gene, found on chromosome1q23, is also linked to migraineattacks. This gene codes for theα 2subunit <strong>of</strong> the Na + /K + ATPase [8] .Moreover, the dopamine D2 receptorgene is found to be responsible als<strong>of</strong>or increasing the susceptibility tomigraine recurrence [9] .When exposed to the migrainetriggers listed above, the ones withlow threshold (i.e. higher susceptibilityto migraine attacks) will experience ashort wave <strong>of</strong> neural depolarizationin the brain due to the initial release<strong>of</strong> potassium and glutamate in theoccipital lobe and then propagatethroughout the whole cortex at aspeed ranging between 3 and 6 mm/min. This wave is followed by a longerone <strong>of</strong> neural depression known ascortical spreading depression, orsimply CSD [1] . These consecutivealterations in the neural activity in thebrain stimulate the vasoconstriction<strong>of</strong> specific blood vessels in thebrainstem. If the decrease in the bloodflow goes below a critical value, thedifferent symptoms observed duringthe aura phase (e.g. blurred vision,weakness, tingling or numbness <strong>of</strong>the face and extremities) may beinitiated [10] .It should be noted that one thirdonly <strong>of</strong> migraine sufferers passthrough the aura symptoms. The resttwo third, despite the electrical wavedisturbances, have what we callmigraine without aura because thedecrease in blood flow in their brainis not so critical [11] . Some studieshave shown that the disruption <strong>of</strong> thenormal electric status <strong>of</strong> the brainmight affect the performance <strong>of</strong> thehypothalamus causing the differentprodromal signs observed severalhours (or even days) before themigraine, like mood disturbances,food cravings, drowsiness, thirst, andyawning [12] .MIDDLE EAST JOURNAL OF FAMILY MEDICINE • VOLUME 6, ISSUE 6 29

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!